Glucagon-Like Peptide-1 Is a Marker of Systemic Inflammation in Patients Treated with High-Dose Chemotherapy and Autologous Stem Cell Transplantation-Reference-Cited by-同舟云学术

Glucagon-Like Peptide-1 Is a Marker of Systemic Inflammation in Patients Treated with High-Dose Chemotherapy and Autologous Stem Cell Transplantation

Published:2019-06 Issue:6 Volume:25 Page:1085-1091
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Ebbesen Maria Schou^ORCID,Kissow Hannelouise,Hartmann Bolette,Grell Kathrine,Gørløv Jette Sønderskov,Kielsen Katrine,Holst Jens Juul,Müller Klaus

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference78 articles.

1. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma;Philip;N Engl J Med,1995

2. Infectious complications after high-dose chemotherapy and autologous stem cell transplantation: Comparison between patients with lymphoma or multiple myeloma and patients with solid tumors;Reich;Bone Marrow Transplant,2001

3. Oral mucositis and outcomes of autologous hematopoietic stem-cell transplantation following high-dose melphalan conditioning for multiple myeloma;Vera-Llonch;J Support Oncol,2007

4. Intestinal damage determines the inflammatory response and early complications in patients receiving conditioning for a stem cell transplantation;van der Velden;PLoS One,2010

5. Sensing danger: toll-like receptors and outcome in allogeneic hematopoietic stem cell transplantation;Kornblit;Bone Marrow Transplant,2017

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bone remodeling in survivors of pediatric hematopoietic stem cell transplantation: Impact of heavy resistance training;Pediatric Blood & Cancer;2024-07-02

2. Design and rationale for the SIB trial: a randomized parallel comparison of semaglutide versus placebo on intestinal barrier function in type 2 diabetes mellitus;Therapeutic Advances in Endocrinology and Metabolism;2023-01

3. The anti-inflammatory feature of glucagon-like peptide-1 and its based diabetes drugs—Therapeutic potential exploration in lung injury;Acta Pharmaceutica Sinica B;2022-11

4. Divergent roles for the gut intraepithelial lymphocyte GLP-1R in control of metabolism, microbiota, and T cell-induced inflammation;Cell Metabolism;2022-10

5. Metabolic Dysregulation in Adult Survivors of Pediatric Hematopoietic Stem Cell Transplantation: The Role of Incretins;The Journal of Clinical Endocrinology & Metabolism;2022-10-01